Trust Company of Vermont’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-100
| Closed | -$8.67K | – | 817 |
|
|
2023
Q2 | $8.67K | Hold |
100
| – | – | ﹤0.01% | 691 |
|
|
2023
Q1 | $9.72K | Hold |
100
| – | – | ﹤0.01% | 713 |
|
|
2022
Q4 | $10.3K | Hold |
100
| – | – | ﹤0.01% | 683 |
|
|
2022
Q3 | $8K | Buy |
100
+71
| +245% | +$5.68K | ﹤0.01% | 750 |
|
|
2022
Q2 | $2K | Buy |
+29
| New | +$2K | ﹤0.01% | 854 |
|
|
2021
Q1 | – | Sell |
-100
| Closed | -$9K | – | 758 |
|
|
2020
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 635 |
|
|
2020
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 625 |
|
|
2020
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 594 |
|
|
2020
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2019
Q4 | $8K | Sell |
100
-150
| -60% | -$12K | ﹤0.01% | 732 |
|
|
2019
Q3 | $17K | Sell |
250
-250
| -50% | -$17K | ﹤0.01% | 649 |
|
|
2019
Q2 | $43K | Hold |
500
| – | – | ﹤0.01% | 501 |
|
|
2019
Q1 | $44K | Buy |
+500
| New | +$44K | ﹤0.01% | 489 |
|